文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

患者自控镇痛治疗急诊科急性疼痛的比较有效性

Comparative Effectiveness of Patient-Controlled Analgesia for Treating Acute Pain in the Emergency Department.
PubMed 文献 · Ann Emerg Med · 2017-01-01
一句话结论在4个急诊科进行的实用性随机对照试验显示,患者自控镇痛(PCA)较常规镇痛在疼痛评分下降速率上差异未达临床显著阈值,且镇痛起效更慢、不良事件更多,作者认为该结果不支持PCA优于急诊常规镇痛。

该实用性随机对照试验在4个急诊科纳入636例18至65岁、需静脉阿片类药物的急性疼痛患者,比较吗啡PCA与常规镇痛(阿片类药物及剂量由医生决定)。主要终点为基线后30至120分钟数字评定量表疼痛评分下降速率,PCA组下降更快(差值1.0个数字评定量表单位,95%CI 0.6至1.5,P<.001),但未达预设的1.3个单位临床显著阈值。PCA组对疼痛管理满意的患者更多(差值9.3%,95%CI 3.3%至15.1%),但初始镇痛中位时间延长15分钟(95%CI 11.4至18.6分钟),不良事件PCA组7例 vs 常规组1例(差值2.0%,95%CI 0.04%至3.9%),另有11起泵编程错误。作者结论认为该研究结果不支持PCA优于急诊常规镇痛。

要点

  • 在4个急诊科636例急性疼痛患者中,PCA组30至120分钟疼痛评分下降速率较常规镇痛组快1.0个数字评定量表单位(95%CI 0.6至1.5,P<.001),但未达到预设的1.3个单位临床显著阈值。
  • PCA组对疼痛管理满意的患者比例较常规镇痛组高9.3%(95%CI 3.3%至15.1%)。
  • PCA组初始镇痛中位时间较常规镇痛组延长15分钟(95%CI 11.4至18.6分钟)。
  • PCA组发生7例不良事件,常规镇痛组1例(差值2.0%,95%CI 0.04%至3.9%),另有11起泵编程错误。
  • 作者结论认为该研究结果不支持PCA优于急诊常规镇痛用于急性疼痛管理。

适用人群与场景

  • 4个急诊科中年龄18至65岁、需要静脉阿片类药物的急性疼痛患者。

处置流程与药物剂量

  • 干预组经患者自控镇痛泵给予吗啡;对照组给予阿片类药物及剂量由医生决定的常规镇痛。
  • 预设的组间临床显著差异为斜率差异相当于1.3个数字评定量表单位。

研究设计与关键结果

  • 研究类型为实用性随机对照试验,在4个急诊科纳入636例患者,比较吗啡PCA与常规镇痛(阿片类药物及剂量由医生决定)。
  • 主要终点:30至120分钟疼痛评分下降速率PCA组大于常规镇痛组,差值1.0个数字评定量表单位(95%CI 0.6至1.5,P<.001),但未达到1.3个单位的临床显著阈值。
  • 次要终点:PCA组对疼痛管理满意者较常规组多9.3%(95%CI 3.3%至15.1%);初始镇痛中位时间PCA组较常规组延长15分钟(95%CI 11.4至18.6分钟)。
  • 不良事件:PCA组7例 vs 常规组1例(差值2.0%,95%CI 0.04%至3.9%);另有11起泵编程错误。
  • 作者结论:研究结果不支持PCA优于急诊常规镇痛用于急性疼痛管理。

证据类型、等级与局限

  • 证据类型:实用性随机对照试验。
  • 预设的组间临床显著差异为斜率差异相当于1.3个数字评定量表单位,实际差值1.0个单位(95%CI 0.6至1.5)未达该阈值。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为该研究结果不支持PCA优于急诊常规镇痛用于急性疼痛管理。
  • 在急诊急性疼痛患者中,PCA组初始镇痛中位时间较常规镇痛组延长15分钟(95%CI 11.4至18.6分钟),且发生11起泵编程错误。
  • PCA组不良事件7例 vs 常规组1例(差值2.0%,95%CI 0.04%至3.9%)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: We assess the effectiveness of patient-controlled analgesia in the emergency department (ED). We hypothesized that decline in pain intensity from 30 to 120 minutes after initial intravenous opioid administration is greater in patients receiving morphine by patient-controlled analgesia compared with usual care and would differ by a clinically significant amount.

METHOD: This was a pragmatic randomized controlled trial of patient-controlled analgesia and usual care (opioid and dose at physician's discretion) in 4 EDs. Entry criteria included age 18 to 65 years and acute pain requiring intravenous opioids. The primary outcome was decline in numeric rating scale pain score 30 to 120 minutes postbaseline. Secondary outcomes included satisfaction, time to analgesia, adverse events, and patient-controlled analgesia pump-related problems. We used a mixed-effects linear model to compare rate of decline in pain (slope) between groups. A clinically significant difference between groups was defined as a difference in slopes equivalent to 1.3 numeric rating scale units.

RESULTS: Six hundred thirty-six patients were enrolled. The rate of decline in pain from 30 to 120 minutes was greater for patients receiving patient-controlled analgesia than usual care (difference=1.0 numeric rating scale unit; 95% confidence interval [CI] 0.6 to 1.5; P<.001) but did not reach the threshold for clinical significance. More patients receiving patient-controlled analgesia were satisfied with pain management (difference=9.3%; 95% CI 3.3% to 15.1%). Median time to initial analgesia was 15 minutes longer for patient-controlled analgesia than usual care (95% CI 11.4 to 18.6 minutes). There were 7 adverse events in the patient-controlled analgesia group and 1 in the usual care group (difference=2.0%; 95% CI 0.04% to 3.9%), and 11 pump-programming errors.

CONCLUSION: The findings of this study do not favor patient-controlled analgesia over usual ED care for acute pain management.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Bijur PE, Mills AM, Chang AK, et al. Comparative Effectiveness of Patient-Controlled Analgesia for Treating Acute Pain in the Emergency Department. Ann Emerg Med. 2017. PMID: 28601270. doi:10.1016/j.annemergmed.2017.03.064

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。